KINETO Lab

KINETO Lab is a Hungarian biotechnology company and contract research organization (CRO) specializing in oncology drug discovery and preclinical development. Founded in 2007, the company provides a comprehensive suite of services including in vitro cell-based assays, in vivo xenograft and allograft models, and a proprietary biobank of patient-derived tumor xenografts (PDTX). KINETO Lab is actively involved in international research consortia such as 'Magicbullet::Reloaded' and 'BIOSMALL,' focusing on the development of peptide-drug conjugates and small molecule inhibitors. Their internal R&D programs target KRAS mutations, tumor endothelial markers, and a next-generation vaccine platform for Parkinson's disease. The company supports global pharmaceutical and biotech partners in accelerating the transition of anticancer candidates from target identification to the clinical stage.